抗肿瘤药物诱导具有功能性补充囊性纤维化跨膜传导调节因子作用的蛋白质：一种治疗囊性纤维化的新疗法？ - Suppr

Suppr

超能文献

Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis?

作者信息

Lallemand J Y, Stoven V, Annereau J P, Boucher J, Blanquet S, Barthe J, Lenoir G

出版信息

Lancet. 1997 Sep 6;350(9079):711-2. doi: 10.1016/s0140-6736(05)63510-6.

DOI:10.1016/s0140-6736(05)63510-6

PMID:9291908

Abstract

摘要

相似文献

Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis?抗肿瘤药物诱导具有功能性补充囊性纤维化跨膜传导调节因子作用的蛋白质：一种治疗囊性纤维化的新疗法？

Lancet. 1997 Sep 6;350(9079):711-2. doi: 10.1016/s0140-6736(05)63510-6.

Improvement of cystic fibrosis using antitumoral drugs: a hypothesis.使用抗肿瘤药物改善囊性纤维化：一种假说。

Med Hypotheses. 2000 Apr;54(4):580-1. doi: 10.1054/mehy.1999.0899.

Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.囊性纤维化是一种囊性纤维化跨膜传导调节蛋白糖蛋白加工错误的疾病。

Am J Hum Genet. 1999 Jun;64(6):1499-504. doi: 10.1086/302429.

CFTR structure and cystic fibrosis.囊性纤维化跨膜传导调节因子结构与囊性纤维化

Int J Biochem Cell Biol. 2014 Jul;52:15-25. doi: 10.1016/j.biocel.2014.02.004. Epub 2014 Feb 15.

Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.囊性纤维化患者CFTR功能的药理学诱导：突变特异性疗法。

Pediatr Pulmonol. 2005 Sep;40(3):183-96. doi: 10.1002/ppul.20200.

Functional interaction of the cystic fibrosis transmembrane conductance regulator with members of the SLC26 family of anion transporters (SLC26A8 and SLC26A9): physiological and pathophysiological relevance.囊性纤维化跨膜传导调节因子与阴离子转运体SLC26家族成员（SLC26A8和SLC26A9）的功能相互作用：生理和病理生理相关性

Int J Biochem Cell Biol. 2014 Jul;52:58-67. doi: 10.1016/j.biocel.2014.02.001. Epub 2014 Feb 14.

Nonstop treatment of cystic fibrosis.囊性纤维化的不间断治疗。

Nat Med. 1996 Jun;2(6):608-9. doi: 10.1038/nm0696-608b.

Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.用于囊性纤维化跨膜传导调节因子研究的分子建模方法。

Int J Biochem Cell Biol. 2014 Jul;52:39-46. doi: 10.1016/j.biocel.2014.04.004. Epub 2014 Apr 13.

[Cystic fibrosis: chemical drugs to cure genetic diseases].[囊性纤维化：用于治疗遗传疾病的化学药物]

Bull Acad Natl Med. 2005 May;189(5):789-95; discussion 795-6.

Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.鲁马卡托和依伐卡托用于囊性纤维化患者的治疗：当前证据与未来前景

Ther Adv Respir Dis. 2015 Dec;9(6):313-26. doi: 10.1177/1753465815601934. Epub 2015 Sep 28.

引用本文的文献

' "Meet the Editors Series": a profile of Christina Sizun.“编辑见面会系列”：克里斯蒂娜·西尊简介

Biophys Rev. 2023 Jun 3;15(3):301-304. doi: 10.1007/s12551-023-01071-8. eCollection 2023 Jun.

Increasing incidence rate of breast cancer in cystic fibrosis - relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and prognosis of cystic fibrosis due to estrogens.囊性纤维化中乳腺癌发病率的增加 - 在雌激素导致囊性纤维化临床结局和预后更差的背景下，发病机制、致癌作用和治疗效果预测之间的关系。

Orphanet J Rare Dis. 2023 Mar 20;18(1):62. doi: 10.1186/s13023-023-02671-z.

Osteogenic Sarcoma in an Adolescent With Cystic Fibrosis: Successful Treatment Despite Significant Obstacles.一名患有囊性纤维化的青少年的骨肉瘤：尽管面临重大障碍仍成功治愈

Front Pediatr. 2018 Sep 21;6:245. doi: 10.3389/fped.2018.00245. eCollection 2018.

Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis.血浆诱导的ABCC1 mRNA在囊性纤维化中的表达增加。

Int J Mol Sci. 2017 Aug 11;18(8):1752. doi: 10.3390/ijms18081752.

Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis.解析 miRNA 转录因子前馈回路，以鉴定囊性纤维化的药物再利用候选物。

Genome Med. 2014 Dec 2;6(12):94. doi: 10.1186/s13073-014-0094-2. eCollection 2014.

Inhaled chemotherapy in lung cancer: future concept of nanomedicine.肺癌的吸入化疗：纳米医学的未来概念。

Int J Nanomedicine. 2012;7:1551-72. doi: 10.2147/IJN.S29997. Epub 2012 Mar 22.

Mechanisms of action and clinical application of macrolides as immunomodulatory medications.大环内酯类作为免疫调节药物的作用机制和临床应用。

Clin Microbiol Rev. 2010 Jul;23(3):590-615. doi: 10.1128/CMR.00078-09.

Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.大环内酯类抗生素在呼吸道疾病中的免疫调节作用：对哮喘和囊性纤维化的治疗意义。

Paediatr Drugs. 2007;9(2):107-18. doi: 10.2165/00148581-200709020-00004.

The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its relevance for cystic fibrosis.MRP1基因5'非翻译区的GCC重复长度具有多态性：其与囊性纤维化相关性的功能特性研究

BMC Med Genet. 2006 Feb 7;7:7. doi: 10.1186/1471-2350-7-7.

Macrolides in the respiratory tract in cystic fibrosis.囊性纤维化患者呼吸道中的大环内酯类药物

J R Soc Med. 2002;95 Suppl 41(Suppl 41):27-31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验